公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2016 | Efficacy of tofacitinib for the treatment of moderate-to-severe chronic plaque psoriasis in patient subgroups from two randomised phase 3 trials | Menter M.A.; Papp K.A.; Cather J.; Leonardi C.; Pariser D.M.; Krueger J.G.; Wohlrab J.; Amaya-Guerra M.; Kaszuba A.; Nadashkevich O.; TSEN-FANG TSAI ; Gupta P.; Tan H.; Valdez H.; Mallbris L.; Tatulych S. | Journal of Drugs in Dermatology | 22 | 23 | |
2012 | The safety of ustekinumab treatment in patients with moderate-to-severe psoriasis and latent tuberculosis infection | TSEN-FANG TSAI ; Ho V.; Song M.; Szapary P.; Kato T.; Wasfi Y.; Li S.; Shen Y.K.; Leonardi C. | British Journal of Dermatology | 83 | 64 |